Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

NCT01190761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Galantamine 4 mg Tablet, single dose
DRUG: Reminyl 4 mg Tablet, single dose

Sponsor

Actavis Inc.